Page 10 - Remunity Pump News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Coldstream Capital Management Inc. grew its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,094 shares of the biotechnology company’s stock after purchasing an additional 86 shares during the period. Coldstream […]

StockNews.com assumed coverage on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a research report released on Thursday morning. The firm issued a buy rating on the biotechnology company’s stock. UTHR has been the topic of a number of other research reports. HC Wainwright restated a buy rating and set a $300.00 price objective […]

TFB Advisors LLC increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 28.3% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,954 shares of the biotechnology company’s stock after acquiring an additional 431 shares during the quarter. […]

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 6,000 shares of the business’s stock in a transaction that occurred on Thursday, September 21st. The shares were sold at an average price of $222.19, for a total value of $1,333,140.00. Following the completion of the sale, the executive vice president now […]

Harel Insurance Investments & Financial Services Ltd. lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 36.8% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 10,051 shares of the biotechnology company’s stock after selling 5,841 shares during the quarter. Harel Insurance Investments & Financial Services Ltd.’s holdings in […]